Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase

No abstract is available for this paper.

• Publication year

  2005

• Venue

  EMBO Journal

• Publication date

  2005-02-23

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.emboj.7600499PMID 15692574PMCID PMC549610
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Global Epidemiology of Tuberculosis

  2018cited by this paper
• The X-ray analysis of the structure of rifamycin B

  2005cited by this paper
• RNA polymerase rifampicin resistance mutations in Escherichia coli: Sequence changes and dominance

  2004influential reference
• New inhibitors targeting bacterial RNA polymerase.

  2004cited by this paper
• Mutation to rifampicin resistance at the beginning of the RNA polymerase β subunit gene in Escherichia coli

  2004cited by this paper
• Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants.

  2004cited by this paper
• Preparation and characterization of recombinant Thermus aquaticus RNA polymerase.

  2003cited by this paper
• Use of TLS parameters to model anisotropic displacements in macromolecular refinement.

  2001influential reference
• Recombinant Thermus aquaticus RNA Polymerase, a New Tool for Structure-Based Analysis of Transcription

  2001cited by this paper
• Structural mechanism for rifampicin inhibition of bacterial rna polymerase.

  2001influential reference
• RNA Polymerase Inhibitors with Activity against Rifampin-Resistant Mutants of Staphylococcus aureus

  2000cited by this paper
• Mutations in the Beginning of the rpoBGene Can Induce Resistance to Rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis

  2000cited by this paper
• A structural model of transcription elongation.

  2000cited by this paper
• A Structural Model of Transcription Elongation

  2000cited by this paper
• Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution.

  1999influential reference
• Bi-cycling the furin pathway: from TGN localization to pathogen activation and embryogenesis.

  1999cited by this paper
• Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

  1998influential reference
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997influential reference
• Molecular Recognition of Proteinminus signLigand Complexes: Applications to Drug Design.

  1997cited by this paper
• Refinement of macromolecular structures by the maximum-likelihood method.

  1997cited by this paper
• MOLECULAR RECOGNITION OF PROTEIN-LIGAND COMPLEXES : APPLICATIONS TO DRUG DESIGN

  1997cited by this paper
• Streptolydigin-resistant Mutants in an Evolutionarily Conserved Region of the β′ Subunit of Escherichia coli RNA Polymerase (*)

  1995cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions.

  1995cited by this paper
• Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

  1995cited by this paper
• RifR mutations in the beginning of the Escherichia coli rpoB gene

  1994influential reference
• Antibiotics from Gliding Bacteria. Part 50. Chemical Modification of Sorangicin A and Structure-Activity Relationship II: Derivatives Obtained by Reduction, Oxidation and Rearrangement Reactions.

  1993cited by this paper
• Recombinant Escherichia coli RNA polymerase: purification of individually overexpressed subunits and in vitro assembly.

  1993cited by this paper
• Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase.

  1993influential reference
• Über die radikalische Desoxygenierung sekundärer Alkohole

  1992cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991cited by this paper
• Antibiotics from gliding bacteria, XLII. Chemical modification of sorangicin A and structure — Activity relationship I: Carboxyl and hydroxyl group derivatives

  1990cited by this paper
• Resistance of Escherichia coli to rifampicin and sorangicin A--a comparison.

  1990influential reference
• Antibiotika aus Gleitenden Bakterien, XXXVII. Sorangicin A, ein hochwirksames Antibiotikum mit neuartiger Makrolid-Polyether-Struktur aus Sorangium cellulosum, So ce12: Spektroskopische Strukturaufklärung, Kristall- und Lösungsstruktur

  1989cited by this paper
• Antibiotics from Gliding Bacteria. Part 37. Sorangicin A, a Highly Active Antibiotic with Novel Macrolide-Polyether Structure from Sorangium cellulosum, So ce12: Spectroscopic Structure Elucidation, Crystal and Solution Structure.

  1989cited by this paper
• Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

  1988cited by this paper
• The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria.

  1987influential reference
• Isolation and spectroscopic structure elucidation of sorangicin a, a new type of macrolide-polyether antibiotic from gliding bacteria - XXX.☆

  1985cited by this paper
• Correlation of structure and activity in ansamycins: molecular structure of cyclized rifamycin SV.

  1984influential reference
• History of the development of rifampin.

  1983cited by this paper
• Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV.

  1983cited by this paper
• Structural investigations of mode of action of drugs. III. Structure of rifamycin S iminomethyl ether

  1981cited by this paper
• Structural investigations of mode of action of drugs. II. Molecular structure of anthramycin methyl ether monohydrate

  1979cited by this paper
• On the mechanism of rifampicin inhibition of RNA synthesis.

  1978cited by this paper
• Ansamycins. Chemistry, biosynthesis and biological activity.

  1977cited by this paper
• Inhibition of RNA polymerase by streptolydigin.

  1972influential reference
• Inhibition of RNA polymerase by streptolydigin.

  1971cited by this paper
• Action of rifamycin on RNA-polymerase from sensitive and resistant bacteria.

  1968cited by this paper
• Mutations affecting RNA Polymerase associated with Rifampicin Resistance in Escherichia coli

  1968cited by this paper
• The X-ray analysis of the structure of rifamycin Y

  1964cited by this paper
• Rifomycin. I. Isolation and properties of rifomycin B and rifomycin complex.

  1959cited by this paper
• Microbial selection.

  1952cited by this paper
• Microbial Selection.

  1952cited by this paper

• Structure Elucidation, Biosynthesis and Biological Evaluation of Neosorangicin A, a Member of the Sorangicin Family

  2026cites this paper
• Molecular basis for noncanonical transcription initiation from Np4A alarmones.

  2025cites this paper
• Bimodality in E. coli gene expression: Sources and robustness to genome-wide stresses

  2025cites this paper
• True-atomic-resolution insights into the interactions of antibiotic rifampicin and rifamycin derivatives with orphan CYP143 of M.tuberculosis

  2025cites this paper
• Natural sideromycins and siderophore-conjugated natural products as inspiration for novel antimicrobial agents.

  2025cites this paper
• Targeting Bacterial RNA Polymerase: Harnessing Simulations and Machine Learning to Design Inhibitors for Drug-Resistant Pathogens.

  2025cites this paper
• Molecular chameleons adaptability in target binding

  2025cites this paper
• Synthesis and antibiotic potential of myxocoumarin-inspired chromene dione analogs

  2024cites this paper
• Heterologous biosynthesis of myxobacterial lanthipeptides melittapeptins

  2024cites this paper
• Inhibiting the oligomerization of mycobacterial DNA-directed RNA polymerase (RNAP) using natural compound via in-silico techniques

  2024cites this paper
• Inhibitory effect of sorangicin A against mutant DNA-dependent RNA polymerase in the obligate intracellular bacterium Chlamydia trachomatis.

  2024cites this paper
• Discovery of the Pendulisporaceae: An extremotolerant myxobacterial family with distinct sporulation behavior and prolific specialized metabolism

  2024cites this paper
• Transcription Attenuation in Synthetic Promoters in Nonoverlapping Tandem Formation

  2024cites this paper
• Transcription attenuation in synthetic promoters in tandem formation

  2023influential citation
• Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos

  2023cites this paper
• Myxobacteria: Biology and bioactive secondary metabolites.

  2023cites this paper
• Siderophore conjugation with cleavable linkers boosts the potency of RNA polymerase inhibitors against multidrug-resistant E. coli

  2023cites this paper
• Synthesis and Characterization of DOTAM-Based Sideromycins for Bacterial Imaging and Antimicrobial Therapy

  2023cites this paper
• Structure-activity relationships of actively FhuE transported rifabutin derivatives with potent activity against Acinetobacter baumannii.

  2023cites this paper
• Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex

  2022influential citation
• M. tuberculosis Transcription Machinery: A Review on the Mycobacterial RNA Polymerase and Drug Discovery Efforts

  2022influential citation
• Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi.

  2022cites this paper
• Modifications, biological origin and antibacterial activity of naphthalenoid ansamycins.

  2022cites this paper
• An Optimized Workflow for the Discovery of New Antimicrobial Compounds Targeting Bacterial RNA Polymerase Complex Formation

  2022cites this paper
• Myxobacteria as a Source of New Bioactive Compounds: A Perspective Study

  2021cites this paper
• Diverse and unified mechanisms of transcription initiation in bacteria

  2020cites this paper
• Potential RNA-dependent RNA polymerase inhibitors as prospective therapeutics against SARS-CoV-2

  2020cites this paper
• One-pot strategy: A highly economical tool in organic synthesis and medicinal chemistry

  2020cites this paper
• Solution conformations explain the chameleonic behaviour of macrocyclic drugs.

  2020cites this paper
• The antibiotic sorangicin A inhibits promoter DNA unwinding in a Mycobacterium tuberculosis rifampicin-resistant RNA polymerase

  2020cites this paper
• Structures of lipoprotein signal peptidase II from Staphylococcus aureus complexed with antibiotics globomycin and myxovirescin

  2020cites this paper
• Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: molecular docking, molecular dynamics simulations and MM-PBSA analyses

  2020cites this paper
• Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients

  2019cites this paper
• Mechanisms of antibiotics inhibiting bacterial RNA polymerase.

  2019cites this paper
• [New inhibitors targeting bacterial RNA polymerase].

  2019cites this paper
• Synthesis, docking and antibacterial studies of more potent amine and hydrazone rifamycin congeners than rifampicin.

  2019cites this paper
• Selecting lipopeptide‐producing, Fusarium‐suppressing Bacillus spp.: Metabolomic and genomic probing of Bacillus velezensis NWUMFkBS10.5

  2018cites this paper
• Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis

  2018cites this paper
• Understanding molecular consequences of putative drug resistant mutations in Mycobacterium tuberculosis

  2018cites this paper
• Synthesis of siderophore-based conjugates to detect and treat bacterial infections.

  2018cites this paper
• Novel inhibitors of RNA polymerase and mechanisms of their action

  2018cites this paper
• A short convergent synthesis of the [3.2.1]dioxabicyclooctane subunit of sorangicin A via regioselective epoxide opening

  2018cites this paper
• Structural basis of transcription inhibition by fidaxomicin (lipiarmycin A3)

  2017cites this paper
• Quadruplex PCR assay for identification of Corynebacterium pseudotuberculosis differentiating biovar Ovis and Equi

  2017cites this paper
• Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights.

  2017cites this paper
• Structural basis for rifamycin resistance of bacterial RNA polymerase by the three most clinically important RpoB mutations found in Mycobacterium tuberculosis

  2017cites this paper
• Evaluation of growth inhibition activity of myxobacterial extracts against multi-drug resistant Acinetobacter baumannii

  2017cites this paper
• Title An In Silico Study of a Novel rpoB Insertion in a Cluster of Clinical Strains of Mycobacterium tuberculosis Highly-Rifampicin Resistant Author names and affiliations

  2017cites this paper
• Structural and Functional Studies of Mycobacterial General Transcription Factors RbpA and CarD

  2017cites this paper
• Insights into RpoB clinical mutants in mediating rifampicin resistance in Mycobacterium tuberculosis.

  2016cites this paper
• Evidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain.

  2016cites this paper
• Bacterial Transcription as a Target for Antibacterial Drug Development

  2016cites this paper
• New antibiotics from Nature's chemical inventory.

  2016cites this paper
• Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert MTB/RIF in Khyber Pakhtunkhwa, Pakistan: a retrospective study

  2016cites this paper
• Rôle de la sous-unité sigma de l'ARN polymérase bactérienne dans la tolérance aux antibiotiques

  2016influential citation
• Sorazolons, Carbazole Alkaloids from Sorangium cellulosum Strain Soce375.

  2016cites this paper
• Bacterial RNA Polymerase-DNA Interaction—The Driving Force of Gene Expression and the Target for Drug Action

  2016cites this paper
• Biosynthesis of polyketides by trans-AT polyketide synthases.

  2016cites this paper
• Shared active site architecture between archaeal PolD and multi-subunit RNA polymerases revealed by X-ray crystallography

  2016cites this paper
• Structure-activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases.

  2016cites this paper
• Rifampicin- and Rifabutin-Resistant Listeria monocytogenes Strains Isolated from Food Products Carry Mutations in rpoB Gene

  2016cites this paper
• Regio‐ and Stereoselective Synthesis of Acetallic Tetrahydropyrans as Building Blocks for Natural Products Preparation, via a Tandem [4+3]‐Cycloaddition/Ozonolysis Process

  2016cites this paper
• Structural Biology of Bacterial RNA Polymerase

  2015cites this paper
• Study of Functional and Allosteric Sites in Protein Superfamilies

  2015cites this paper
• The effect of complexation of 3-formylrifamycin SV macrocyclic ether derivatives with metal cations and small nitrogen-containing organic molecules on antibacterial activity against S. aureus and S. epidermidis.

  2015cites this paper
• Mutations in the CRE pocket of bacterial RNA polymerase affect multiple steps of transcription

  2015cites this paper
• Rifampicin-resistance, rpoB polymorphism and RNA polymerase genetic engineering.

  2015cites this paper
• The role of novel molecular techniques for tuberculosis diagnostics in the WHO European Region.

  2015cites this paper
• RNA POLYMERASE INHIBITOR ACTIVITY AGAINST STAPHYLOCOCCUS EPIDERMIDIS BIOFILMS

  2014cites this paper
• Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results

  2014influential citation
• Antibiotic Streptolydigin Requires Noncatalytic Mg 2 (cid:2) for Binding to RNA Polymerase

  2014cites this paper
• GE23077 binds to the RNA polymerase ‘i’ and ‘i+1’ sites and prevents the binding of initiating nucleotides

  2014influential citation
• Molecular basis of RNA polymerase promoter specificity switch revealed through studies of Thermus bacteriophage transcription regulator

  2014cites this paper
• Inhibitors of bacterial transcription are compounds for potent antimicrobial drugs.

  2014cites this paper
• Distinct functions of the RNA polymerase σ subunit region 3.2 in RNA priming and promoter escape

  2014cites this paper
• RNA polymerase inhibitor activity against Staphylococcus epidermidis biofilms

  2014cites this paper
• The Cornerstone of Nucleic Acid-Affecting Antibiotics in Bacteria

  2014cites this paper
• Antibiotics from myxobacteria.

  2014cites this paper
• Resistance to rifampicin: a review

  2014cites this paper
• Antibiotic Streptolydigin Requires Noncatalytic Mg2+ for Binding to RNA Polymerase

  2013cites this paper
• Prospects for new antibiotics: a molecule-centered perspective

  2013cites this paper
• X-ray Crystal Structure of Escherichia coli RNA Polymerase σ70 Holoenzyme*

  2013cites this paper
• Antibiotics Targeting Bacterial RNA Polymerase

  2013cites this paper
• Structural basis of transcription elongation.

  2013cites this paper
• Holoenzyme 70 σ RNA Polymerase Escherichia coli X-ray Crystal Structure of Gene Regulation

  2013cites this paper
• Molecular docking between the RNA polymerase of the Moniliophthora perniciosa mitochondrial plasmid and Rifampicin produces a highly stable complex

  2013cites this paper
• The efficacy of rifabutin for rifabutin-susceptible, multidrug-resistant tuberculosis.

  2013cites this paper
• Fitness‐compensatory mutations in rifampicin‐resistant RNA polymerase

  2012influential citation
• Molecular Analysis of Rifampin-Resistant Mycobacterium tuberculosis Strains Isolated from Papua, Indonesia

  2012cites this paper
• Fidaxomicin Is an Inhibitor of the Initiation of Bacterial RNA Synthesis

  2012cites this paper
• Structural and Mechanistic Basis for the Inhibition of Escherichia coli RNA Polymerase by T7 Gp2

  2012cites this paper
• Intramolecular proton transfer impact on antibacterial properties of ansamycin antibiotic rifampicin and its new amino analogues.

  2012cites this paper
• A new model of binding of rifampicin and its amino analogues as zwitterions to bacterial RNA polymerase.

  2012cites this paper
• Inhibition of Mycobacterium tuberculosis RNA polymerase by 1 binding of a Gre factor homolog to secondary channel 2 3 4

  2011cites this paper
• Inhibition of Mycobacterium tuberculosis RNA Polymerase by Binding of a Gre Factor Homolog to the Secondary Channel

  2011cites this paper
• Architecture of Escherichia coli promoters that respond to reactive nitrogen species

  2011cites this paper
• Enzymatic methods for glyco(diversification/randomization) of drugs and small molecules.

  2011cites this paper
• Regulation of bacterial transcription elongation

  2011cites this paper
• Discovery of Novel Antimicrobial Agents Targeting the Bacterial RNA Polymerase by High-Throughput Virtual Screening

  2011cites this paper
• Roimatacene: an antibiotic against Gram-negative bacteria isolated from Cystobacter ferrugineus Cb G35 (Myxobacteria).

  2011cites this paper